The serum concentrations of CRP, CEA, CA19-9, and GSDM D according to the sex of the tested patients (a total of patients with bladder cancer and healthy individuals) were also evaluated (Table 4). This evidence concerns the gene CEACAM5 and urinary bladder cancer.